COMPARISON OF PRORENOATE POTASSIUM AND SPIRONOLACTONE AFTER REPEATED DOSES AND STEADY-STATE PLASMA-LEVELS OF ACTIVE METABOLITES

被引:4
作者
MCINNES, GT [1 ]
SHELTON, JR [1 ]
HARRISON, IR [1 ]
PERKINS, RM [1 ]
PALMER, RF [1 ]
机构
[1] GD SEARLE & CO LTD,EUROPEAN CLIN RES,HIGH WYCOMBE HP12 4HL,BUCKINGHAMSHIRE,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1982.tb01354.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:187 / 194
页数:8
相关论文
共 26 条
[1]  
ARMITAGE P, 1971, STATISTICAL METHODS
[2]   MECHANISM OF ACTION OF A NEW ANTIALDOSTERONE COMPOUND, PRORENONE [J].
CLAIRE, M ;
RAFESTINOBLIN, ME ;
MICHAUD, A ;
ROTHMEYER, C ;
CORVOL, P .
ENDOCRINOLOGY, 1979, 104 (04) :1194-1200
[3]   SC23992 - RADIORECEPTOR ASSAYS FOR THERAPEUTIC AND SIDE-EFFECTS [J].
FUNDER, JW ;
MERCER, J ;
HOOD, J .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 51 :S333-S334
[4]   MOLECULAR MODIFICATIONS OF ANTI-ALDOSTERONE COMPOUNDS - EFFECTS ON AFFINITY OF SPIRONOLACTONES FOR RENAL ALDOSTERONE RECEPTORS [J].
FUNDER, JW ;
FELDMAN, D ;
HIGHLAND, E ;
EDELMAN, IS .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (10) :1493-1501
[5]  
GANTT CL, 1963, METABOLISM, V12, P1007
[6]  
GOCHMAN N, 1962, J PHARMACOL EXP THER, V135, P312
[7]  
HOFMAN LM, 1975, J PHARM EXP THER, V154, P450
[8]  
JICK H, 1963, METABOLISM, V12, P381
[10]  
KAGAWA CM, 1964, EVALUATION DRUG ACT, V2, P745